欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-IL-13 mAbs

简要描述:

This antibody binds an epitope at the surface formed by helices A and D of human interleukin- 13. This epitope overlaps with the IL-4Ralpha/IL-13Ralpha1 receptor-binding site, which explains the neutralizing effect of CNTO607. IL-13 is a cytokine secreted by T helper type 2 (Th2) cells, CD4 cells, natural killer T cell, mast cells, basophils, eosinophils and nuocytes. It inhibits the production of inflammatory cytokines (IL-1, IL-6, TNF, IL-8) by LPS-stimulated monocytes. It synergizes with IL2 in regulating interferon- gamma synthesis. It is a mediator of allergic inflammation and different diseases including asthma.

产品参数:

Cat. No.:MABL-2028

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:neutralize, ELISA

详细介绍

Key features and   details


Cat. No.

MABL-2028

Name

Anti-IL-13 mAbs

Clone No.

AFD- CNTO607

From

Recombinant Antibody

Isotype

Engineer antibody

Application

neutralize, ELISA

Species Reactivity

Human

Basic Information


Specificity

This antibody binds an epitope at the   surface formed by helices A and D of human interleukin- 13. This epitope   overlaps with the IL-4Ralpha/IL-13Ralpha1 receptor-binding site, which   explains the neutralizing effect of CNTO607. IL-13 is a cytokine secreted by   T helper type 2 (Th2) cells, CD4 cells, natural killer T cell, mast cells,   basophils, eosinophils and nuocytes. It inhibits the production of   inflammatory cytokines (IL-1, IL-6, TNF, IL-8) by LPS-stimulated monocytes.   It synergizes with IL2 in regulating interferon- gamma synthesis. It is a   mediator of allergic inflammation and different diseases including asthma.

Alternative Name

IL13; NC30; Interleukin-13; MOR3406

UniProt

P35225

Immunogen

The original antibody was generated from   Morphosys HuCAL-Gold™ phage display library after panning against an IL-13   variant (R130Q) identified in a sub-population of patients who suffer from   asthmatic attacks.

Application Notes

The original IgG1 version of this antibody   binds human IL-13 with an affinity of 18pM and prevents binding of IL-13 to   both IL-13Rα1 and IL-4Rα. This antibody can bind native wild type and   recombinant human IL-13 in an ELISA (PMID: 19361524). This antibody is   capable of neutralizing IL13 activity in the TF-1 and in the IL-13Rα1   receptor binding assay (US20080044420). This antibody has the tendency to   self associate. The IgG1 version of this antibody can be concentrated to 13 mg/ml before irreversible precipitation occurs   (PMID: 22915597). The relative binding affinity of the IgG1 version of this   antibody was determined to be 18.4 pM (PMID: 22915597).

Antibody First   Published

Teplyakov et al. Epitope mapping of   anti-interleukin-13 neutralizing antibody CNTO607. J Mol Biol. 2009 May   29;389(1):115-23. PMID:19361524

Note on publication

Describes the epitope mapping of this   antibody using X-ray crystallography.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified   antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity   purified

Buffer

PBS with 0.02% Proclin   300.

Concentration

1 mg/ml.

Storage   Recommendation

Store at 4⁰C for up to 3   months. For longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-IL-13 mAbs

下一篇: Anti-IL-13 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号